Works matching IS 11707690 AND DT 2023 AND VI 41 AND IP 11

Results: 9

Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
2023
By:
- Otten, Thomas;
- Riemsma, Rob;
- Wijnen, Ben;
- Armstrong, Nigel;
- Stirk, Lisa;
- Gordon, Caroline;
- Ramaekers, Bram;
- Kleijnen, Jos;
- Joore, Manuela;
- Grimm, Sabine
Publication type:
Correction Notice
Conducting Trial-Based Economic Evaluations Using R: A Tutorial.
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1403, doi. 10.1007/s40273-023-01301-7
By:
- Ben, Ângela Jornada;
- van Dongen, Johanna M.;
- El Alili, Mohamed;
- Esser, Jonas L.;
- Broulíková, Hana Marie;
- Bosmans, Judith E.
Publication type:
Article
Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model.
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1539, doi. 10.1007/s40273-023-01299-y
By:
- Pahmeier, Kathrin;
- Speckemeier, Christian;
- Neusser, Silke;
- Wasem, Jürgen;
- Biermann-Stallwitz, Janine
Publication type:
Article
Economic and Humanistic Burden of Osteoarthritis: An Updated Systematic Review of Large Sample Studies.
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1453, doi. 10.1007/s40273-023-01296-1
By:
- Jin, Xuejing;
- Liang, Wanxian;
- Zhang, Lining;
- Cao, Shihuan;
- Yang, Lujia;
- Xie, Feng
Publication type:
Article
Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC).
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1437, doi. 10.1007/s40273-023-01295-2
By:
- Jovanoski, Nick;
- Abogunrin, Seye;
- Di Maio, Danilo;
- Belleli, Rossella;
- Hudson, Pollyanna;
- Bhadti, Sneha;
- Jones, Libby G.
Publication type:
Article
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review.
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1415, doi. 10.1007/s40273-023-01293-4
By:
- Heinz, Katja C.;
- Beaudart, Charlotte;
- Willems, Damon;
- Wiethoff, Isabell;
- Hiligsmann, Mickaël
Publication type:
Article
Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia.
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1525, doi. 10.1007/s40273-023-01291-6
By:
- Ngo, Preston;
- Karikios, Deme;
- Goldsbury, David;
- Wade, Stephen;
- Lwin, Zarnie;
- Hughes, Brett G. M.;
- Fong, Kwun M.;
- Canfell, Karen;
- Weber, Marianne
Publication type:
Article
EQ-5D-5L Value Set for Slovenia.
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1515, doi. 10.1007/s40273-023-01280-9
By:
- Prevolnik Rupel, Valentina;
- Ogorevc, Marko
Publication type:
Article
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus.
Published in:
PharmacoEconomics, 2023, v. 41, n. 11, p. 1469, doi. 10.1007/s40273-023-01268-5
By:
- Laursen, Henrik Vitus Bering;
- Jørgensen, Emmelie Ploug;
- Vestergaard, Peter;
- Ehlers, Lars Holger
Publication type:
Article